A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy
Chemical Engineering Journal · 2026-11 · 184401
DOI: 10.1016/j.cej.2026.184401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-11. Verfasst von Xinzhe Feng und 7 weiteren Autor:innen. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The First Affiliated Hospital of Naval Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoarthritis (OA) is a whole-joint disorder characterized by cartilage degradation, synovial inflammation, and subchondral bone remodeling, yet disease-modifying therapies remain limited. Here, we developed an injectable microsphere system (S-Exo@HAMA@PLL) composed of synovial mesenchymal stem cells-derived exosomes associated with recombinant sTREM2 and encapsulated in poly- l -lysine-coated methacrylated hyaluronic acid microspheres. The intraluminal encapsulation efficiency of exosomes within HAMA hydrogels reached approximately 75% by BCA protein quantification and 80–95% recovery of exosomal CD63/CD9 signals after microsphere dissolution, while hemolysis remained below 5% at therapeutically relevant concentrations. S-Exo@HAMA@PLL prolonged intra-articular retention for up to 28 days, reduced oxidative stress, shifted macrophages toward an anti-inflammatory CD206 + /CD163 + phenotype, and restored the balance between matrix-degrading enzymes (MMP13 and ADAMTS5) and cartilage matrix components (COL2A1 and ACAN) in IL-1β-stimulated chondrocyte/macrophage co-culture and in an OA mouse model. Co-culture and pharmacological-perturbation data were consistent with coordinated reductions in PI3K-AKT phosphorylation in macrophages and MAPK13/ERK/JNK-related stress signals in chondrocytes following S-Exo@HAMA@PLL treatment. With demonstrated biocompatibility, inflammation-associated joint retention under the tested conditions, and favorable OA-related outcomes in the tested models, this exosome-based microsphere system represents a promising strategy for OA treatment.
Förderung
- The First Affiliated Hospital of Naval Medical University
- National Natural Science Foundation of China
Zitieren
APA
Feng, X., Zhu, S., Ji, Z., Han, C., Liu, C., Li, Z., Xu, Y., & Xu, W. (2026). A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy. Chemical Engineering Journal, 184401. https://doi.org/10.1016/j.cej.2026.184401
Vancouver
Feng X, Zhu S, Ji Z, Han C, Liu C, Li Z, et al. A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy. Chemical Engineering Journal. 2026:184401. doi:10.1016/j.cej.2026.184401
BibTeX
@article{Feng2026,
author = {Feng, Xinzhe and Zhu, Shanbang and Ji, Zhou and Han, Changhao and Liu, Chenxu and Li, Zhi and Xu, Yihong and Xu, Weidong},
title = {A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy},
journal = {Chemical Engineering Journal},
year = {2026},
pages = {184401},
doi = {10.1016/j.cej.2026.184401}
}
EUVIMED